Werner Geldenhuys

Modulation Therapeutics, Inc.

$2,374,551

Attributed

$4,651,680

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY2017–25

$2M$1.5M$1M$500K$0

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$4,651,680 · 6

By mechanism

R01$1,605,405 · 1

R44$1,457,919 · 1

R41$603,619 · 2

P20$566,737 · 1

R21$418,000 · 1

Top collaborators

Most similar at Modulation Therapeutics, Inc.

Same institution · by research overlap

Lori Hazlehurst$1,674,270
Karen E Hayes$1,245,154

Others in their field

Other Emerging Leaders on “Cells”

Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Evan Z Macosko · Broad Institute, Inc.$33,096,828
James Dale Berry · Brigham And Women'S Hospital$30,122,905
Hanjoon Ryu$28,519,898
Eric C Palm · Florida State University$26,502,247

Research focus

CellsNovel TherapeuticsDesignRattusPathway InteractionsMitochondriaProteinsCause Of DeathPre-ClinicalParentsIn VivoGenesGenerationsLigandsOuter Mitochondrial MembraneMitochondrial DysfunctionMouse ModelClinical TrialsFutureNew Therapeutic TargetBioenergeticsOxidation-ReductionPlayTissues